HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lodewyk F A Wessels Selected Research

Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)

3/2021Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lodewyk F A Wessels Research Topics

Disease

80Neoplasms (Cancer)
05/2024 - 05/2005
38Breast Neoplasms (Breast Cancer)
11/2023 - 05/2005
8Colonic Neoplasms (Colon Cancer)
01/2023 - 11/2012
6Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 02/2014
6Prostatic Neoplasms (Prostate Cancer)
11/2022 - 11/2015
5Neoplasm Metastasis (Metastasis)
01/2020 - 01/2006
4Noninfiltrating Intraductal Carcinoma (DCIS)
01/2023 - 07/2011
4Squamous Cell Carcinoma of Head and Neck
03/2019 - 02/2005
3Inflammation (Inflammations)
04/2024 - 01/2019
3Carcinoma (Carcinomatosis)
03/2019 - 07/2007
3Triple Negative Breast Neoplasms
01/2019 - 10/2015
2Ovarian Neoplasms (Ovarian Cancer)
02/2024 - 12/2022
2Lobular Carcinoma
11/2023 - 01/2020
2Urinary Bladder Neoplasms (Bladder Cancer)
06/2023 - 01/2023
2Hypersensitivity (Allergy)
04/2018 - 05/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024
1Tertiary Lymphoid Structures
01/2021
1Head and Neck Neoplasms (Head and Neck Cancer)
03/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018
1Pathologic Complete Response
01/2018
1Endometrial Neoplasms (Endometrial Cancer)
01/2017

Drug/Important Bio-Agent (IBA)

18Biomarkers (Surrogate Marker)IBA
04/2024 - 07/2014
18DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2005
8Estrogen ReceptorsIBA
01/2020 - 07/2007
7Messenger RNA (mRNA)IBA
01/2023 - 01/2010
7Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2021 - 11/2012
7TamoxifenFDA LinkGeneric
01/2020 - 01/2009
6RNA (Ribonucleic Acid)IBA
04/2024 - 02/2010
6Androgen Receptors (Androgen Receptor)IBA
11/2022 - 11/2015
6ChromatinIBA
11/2022 - 04/2014
5Proteins (Proteins, Gene)FDA Link
02/2024 - 01/2013
5Phosphotransferases (Kinase)IBA
02/2020 - 11/2012
4Immune Checkpoint InhibitorsIBA
03/2024 - 01/2023
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 05/2005
3LigandsIBA
04/2024 - 10/2018
3(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA
11/2023 - 11/2016
3Transcription Factors (Transcription Factor)IBA
02/2020 - 03/2013
3PlatinumIBA
03/2019 - 06/2013
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2015 - 05/2005
2EverolimusFDA Link
11/2023 - 08/2017
2Cisplatin (Platino)FDA LinkGeneric
06/2023 - 01/2023
2Carboplatin (JM8)FDA LinkGeneric
01/2023 - 05/2014
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2023 - 04/2018
2Proteasome Endopeptidase Complex (Proteasome)IBA
12/2021 - 01/2020
2Hormones (Hormone)IBA
02/2020 - 01/2016
2Estrogens (Estrogen)FDA Link
03/2017 - 01/2017
2Small Interfering RNA (siRNA)IBA
03/2017 - 04/2014
2Histones (Histone)IBA
01/2017 - 07/2015
2Trastuzumab (Herceptin)FDA Link
11/2016 - 01/2016
2Formaldehyde (Formol)FDA Link
03/2016 - 02/2011
2Phenobarbital (Luminal)FDA Link
07/2014 - 01/2010
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
05/2014 - 06/2013
2ErbB Receptors (EGF Receptor)IBA
04/2014 - 11/2012
2MicroRNAs (MicroRNA)IBA
01/2014 - 07/2011
1pembrolizumabIBA
04/2024
1B7-H1 AntigenIBA
04/2024
1Cell-Free Nucleic AcidsIBA
02/2024
1AntigensIBA
02/2024
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2024
1CytokinesIBA
01/2024
1InterferonsIBA
01/2024
1MTOR InhibitorsIBA
11/2023
1tetraethylpyrazine (TEP)IBA
01/2023
1Codon (Codons)IBA
01/2023
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2023
1trifluridine tipiracil drug combinationIBA
01/2023
1CyclinsIBA
12/2022
1enzalutamideIBA
01/2022
1AndrogensIBA
01/2022
1TransactIBA
12/2021
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
03/2021
1SenotherapeuticsIBA
01/2021
1IpilimumabIBA
12/2020
1NivolumabIBA
12/2020
1tyrosine receptor (receptor, tyrosine)IBA
02/2020
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
01/2020
1EndonucleasesIBA
01/2020
1Therapeutic UsesIBA
01/2020
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2020
1Programmed Cell Death 1 ReceptorIBA
01/2019
1Poly Adenosine Diphosphate RiboseIBA
11/2018
1Glycoside Hydrolases (Endoglycosidases)IBA
11/2018
1AZD4547IBA
10/2018
1Mitomycin (Mitomycin-C)FDA LinkGeneric
04/2018
1A 19IBA
04/2018
1Mitogen-Activated Protein KinasesIBA
01/2018
1neratinibIBA
01/2018
1Cadherins (E-Cadherin)IBA
08/2017
1Epidermal Growth Factor (EGF)IBA
03/2017
1Lysine (L-Lysine)FDA Link
01/2017
1MK 2206IBA
11/2016

Therapy/Procedure

25Therapeutics
02/2024 - 01/2006
17Drug Therapy (Chemotherapy)
05/2024 - 05/2005
8Neoadjuvant Therapy
06/2023 - 05/2005
3Immunotherapy
02/2024 - 01/2021
2Segmental Mastectomy (Lumpectomy)
12/2021 - 03/2021
2Aftercare (After-Treatment)
01/2021 - 05/2005
2Chemoradiotherapy
03/2019 - 01/2018
1Cystectomy
01/2023
1Transplantation
01/2023